Prelude Capital Management’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-338,673
| Closed | -$11.1M | – | 2191 |
|
|
2022
Q2 | $11.1M | Buy |
+338,673
| New | +$10.7M | 0.32% | 37 |
|
|
2020
Q3 | – | Sell |
-141
| Closed | -$3K | – | 2531 |
|
|
2020
Q2 | $3K | Buy |
+141
| New | +$3.23K | ﹤0.01% | 1807 |
|
|
2019
Q4 | – | Sell |
-400
| Closed | -$13K | – | 2364 |
|
|
2019
Q3 | $13K | Buy |
+400
| New | +$11.7K | ﹤0.01% | 1463 |
|
|
2019
Q2 | – | Sell |
-600
| Closed | -$15K | – | 2278 |
|
|
2019
Q1 | $15K | Buy |
+600
| New | +$17.9K | ﹤0.01% | 1353 |
|
|
2018
Q4 | – | Sell |
-500
| Closed | -$18K | – | 2288 |
|
|
2018
Q3 | $18K | Buy |
+500
| New | +$17.7K | ﹤0.01% | 1334 |
|
|
2018
Q1 | – | Sell |
-2,200
| Closed | -$84K | – | 1791 |
|
|
2017
Q4 | $84K | Sell |
2,200
-173
| -7% | -$6.91K | 0.01% | 831 |
|
|
2017
Q3 | $89K | Buy |
2,373
+673
| +40% | +$23.8K | 0.01% | 919 |
|
|
2017
Q2 | $63K | Sell |
1,700
-1,341
| -44% | -$48.4K | 0.01% | 931 |
|
|
2017
Q1 | $119K | Sell |
3,041
-1,234
| -29% | -$46.3K | 0.01% | 734 |
|
|
2016
Q4 | $149K | Sell |
4,275
-258
| -6% | -$10.1K | 0.02% | 685 |
|
|
2016
Q3 | $178K | Buy |
+4,533
| New | +$181K | 0.02% | 601 |
|
|
2016
Q2 | – | Sell |
-2,700
| Closed | -$104K | – | 1802 |
|
|
2016
Q1 | $104K | Sell |
2,700
-800
| -23% | -$29.8K | 0.01% | 754 |
|
|
2015
Q4 | $168K | Buy |
3,500
+3,366
| +2,512% | +$156K | 0.03% | 645 |
|
|
2015
Q3 | $5K | Sell |
134
-4,066
| -97% | -$173K | ﹤0.01% | 1397 |
|
|
2015
Q2 | $179K | Buy |
4,200
+400
| +11% | +$15.9K | 0.03% | 664 |
|
|
2015
Q1 | $150K | Sell |
3,800
-800
| -17% | -$29.5K | 0.02% | 804 |
|
|
2014
Q4 | $166K | Sell |
4,600
-800
| -15% | -$26.9K | 0.02% | 746 |
|
|
2014
Q3 | $159K | Sell |
5,400
-5,400
| -50% | -$149K | 0.02% | 811 |
|
|
2014
Q2 | $272K | Sell |
10,800
-489
| -4% | -$12.1K | 0.04% | 620 |
|
|
2014
Q1 | $291K | Buy |
+11,289
| New | +$284K | 0.04% | 603 |
|
Other funds holding NTUS
Prelude Capital Management's NTUS Position: Q3 2022 in Review
Prelude Capital Management sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 338,673 shares — an estimated $11.1M sold.
Prelude Capital Management first reported a position in NTUS in Q1 2014 and held it in 20 quarters. The position peaked at $11.1M in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Prelude Capital Management reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Prelude Capital Management sold 338,673 Natus Medical Inc shares in Q3 2022, an estimated $11.1M.
- Prelude Capital Management first reported a position in Natus Medical Inc in Q1 2014 and held it in 20 quarters.
- Prelude Capital Management's Natus Medical Inc position peaked at $11.1M in Q2 2022.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Prelude Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.